https://nl.marketscreener.com/koers/aandeel/APOLLOMICS-INC-152896960/nieuws/Apollomics-voltooit-de-inclusie-in-de-Fase-3-overbruggingsstudie-van-uproleselan-bij-Chinese-patien-45666736/?utm_source=telegram&utm_medium=social&utm_campaign=share